floxacillin has been researched along with isoprene in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Buclin, T; Cochet, C; de Valliere, S; Decosterd, L; Gardiol, C; Van Neyghem, N; Voumard, R | 1 |
Blake, DF; Brown, LH; Hardman, J; Lewis, I; Pain, T; Perks, S; Young, DA | 1 |
Allwood, MC; Hills, T; Jamieson, C; Stonkute, D; Wallace, A; Wilkinson, AS | 1 |
Davis, L; Ody, YC; Zhang, Y | 1 |
4 other study(ies) available for floxacillin and isoprene
Article | Year |
---|---|
Antibiotic stability related to temperature variations in elastomeric pumps used for outpatient parenteral antimicrobial therapy (OPAT).
Topics: Anti-Bacterial Agents; Cefazolin; Cefepime; Cephalosporins; Drug Stability; Elastomers; Female; Floxacillin; Healthy Volunteers; Humans; Infusion Pumps; Male; Piperacillin; Polymers; Temperature | 2017 |
An assessment of the performance of the Baxter elastomeric (LV10) Infusorâ„¢ pump under hyperbaric conditions.
Topics: Anti-Bacterial Agents; Atmospheric Pressure; Ceftazidime; Elastomers; Floxacillin; Healthy Volunteers; Humans; Hyperbaric Oxygenation; Infusion Pumps; Polymers; Temperature; Time Factors | 2017 |
Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Docum
Topics: Anti-Bacterial Agents; Buffers; Citrates; Drug Packaging; Drug Stability; Drug Storage; Elasticity; Elastomers; Floxacillin; Humans; Infusions, Intravenous; Pharmaceutical Solutions; State Medicine; United Kingdom | 2020 |
Clinical effectiveness of flucloxacillin delivery using an elastomeric device for outpatient parenteral antimicrobial therapy.
Topics: Anti-Bacterial Agents; Bacteremia; Betacoronavirus; Community Health Nursing; Coronavirus Infections; COVID-19; Delivery of Health Care; Elastomers; Floxacillin; Home Infusion Therapy; Humans; Infusion Pumps; Infusions, Intravenous; Osteomyelitis; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Spinal Diseases | 2020 |